Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
New insights into the antiviral effects of chloroquine.
Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A. Savarino A, et al. Lancet Infect Dis. 2006 Feb;6(2):67-9. doi: 10.1016/S1473-3099(06)70361-9. Lancet Infect Dis. 2006. PMID: 16439323 Free PMC article. No abstract available.
Effects of chloroquine on viral infections: an old drug against today's diseases?
Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Savarino A, et al. Lancet Infect Dis. 2003 Nov;3(11):722-7. doi: 10.1016/s1473-3099(03)00806-5. Lancet Infect Dis. 2003. PMID: 14592603 Free PMC article. Review.
Chloroquine is a 9-aminoquinoline known since 1934. Apart from its well-known antimalarial effects, the drug has interesting biochemical properties that might be applied against some viral infections. ...We review the available information on the effects of chloroquine on …
Chloroquine is a 9-aminoquinoline known since 1934. Apart from its well-known antimalarial effects, the drug has interesting biochemi …
Use of chloroquine in viral diseases.
Savarino A. Savarino A. Lancet Infect Dis. 2011 Sep;11(9):653-4. doi: 10.1016/S1473-3099(11)70092-5. Epub 2011 May 5. Lancet Infect Dis. 2011. PMID: 21550312 Free PMC article. No abstract available.
On the use of chloroquine for chikungunya.
Savarino A, Cauda R, Cassone A. Savarino A, et al. Lancet Infect Dis. 2007 Oct;7(10):633. doi: 10.1016/S1473-3099(07)70217-7. Lancet Infect Dis. 2007. PMID: 17897603 Free PMC article. No abstract available.
Risks and benefits of chloroquine use in anticancer strategies.
Savarino A, Lucia MB, Giordano F, Cauda R. Savarino A, et al. Lancet Oncol. 2006 Oct;7(10):792-3. doi: 10.1016/S1470-2045(06)70875-0. Lancet Oncol. 2006. PMID: 17012039 No abstract available.
The anti-HIV-1 activity of chloroquine.
Savarino A, Gennero L, Sperber K, Boelaert JR. Savarino A, et al. J Clin Virol. 2001 Feb;20(3):131-5. doi: 10.1016/s1386-6532(00)00139-6. J Clin Virol. 2001. PMID: 11166661 Review.
BACKGROUND: there is a dramatic need for drugs with anti-HIV-1 activity that are affordable for resource-poor countries. Chloroquine (CQ) is one such drug. ...The principal mechanism of HIV-1 inhibition by CQ seems to be an effect on gp120 on a post-transcriptional …
BACKGROUND: there is a dramatic need for drugs with anti-HIV-1 activity that are affordable for resource-poor countries. Chloroquine …
Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors.
Savarino A, Lucia MB, Rastrelli E, Rutella S, Golotta C, Morra E, Tamburrini E, Perno CF, Boelaert JR, Sperber K, Cauda R. Savarino A, et al. J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):223-32. doi: 10.1097/00126334-200403010-00002. J Acquir Immune Defic Syndr. 2004. PMID: 15076236
RESULTS: CQ alone inhibited HIV replication and glycosylation in a dose-dependent manner. In combination with indinavir (IDV), ritonavir, or saquinavir (SQV), CQ had a synergistic effect at concentrations found in plasma of subjects receiving malaria prophylaxis. .. …
RESULTS: CQ alone inhibited HIV replication and glycosylation in a dose-dependent manner. In combination with indinavir (IDV), ritona …
Expanding the frontiers of existing antiviral drugs: possible effects of HIV-1 protease inhibitors against SARS and avian influenza.
Savarino A. Savarino A. J Clin Virol. 2005 Nov;34(3):170-8. doi: 10.1016/j.jcv.2005.03.005. J Clin Virol. 2005. PMID: 15893956 Free PMC article. Review.
When unexpected diseases such as the severe acute respiratory syndrome (SARS) and avian influenza become a serious threat to public health, an immediate response is imperative. ...As suggested by in silico docking of these molecules to a theoretical model of a
When unexpected diseases such as the severe acute respiratory syndrome (SARS) and avian influenza become a serious threat to public h …
Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity.
Savarino A, Gennero L, Chen HC, Serrano D, Malavasi F, Boelaert JR, Sperber K. Savarino A, et al. AIDS. 2001 Nov 23;15(17):2221-9. doi: 10.1097/00002030-200111230-00002. AIDS. 2001. PMID: 11698694
DESIGN AND METHODS: MT-4 cells or peripheral blood mononuclear cells were infected with X4, R5 or R5/X4 HIV-1 strains from clades A-E and HIV-2. ...Although affecting a variable target such as gp120, chloroquine was capable of inhibiting X4, R5 and R5/X4 primary HIV …
DESIGN AND METHODS: MT-4 cells or peripheral blood mononuclear cells were infected with X4, R5 or R5/X4 HIV-1 strains from clades A-E …
Therapeutic imprinting of the immune system: towards a remission of AIDS in primates?
Savarino A, Garaci E. Savarino A, et al. Retrovirology. 2012 Sep 14;9:75. doi: 10.1186/1742-4690-9-75. Retrovirology. 2012. PMID: 22978787 Free PMC article.
In order to develop new strategies, it is certainly essential that a suitable animal model be implemented. In the recent work of Shytaj et al., it has been possible to inhibit viral replication to levels below the assay detection limit in the macaque AIDS model. Moreover, …
In order to develop new strategies, it is certainly essential that a suitable animal model be implemented. In the recent work of Shyt …
84 results
Jump to page
Feedback